Detalhe da pesquisa
1.
Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome.
J Neurol
; 271(1): 254-262, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682316
2.
Physical Activity in Patients with Neuromuscular Disease Three Years after COVID-19, a Longitudinal Survey: The After-Effects of the Quarantine and the Benefits of a Return to a Healthier Life-Style.
J Clin Med
; 13(1)2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38202272
3.
Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows.
Brain Sci
; 13(9)2023 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37759888